Myelodysplastic syndrome drug development and combination therapy

Update on the phase III VISTA trial

Romidepsin treatment in peripheral T cell lymphoma and subsets

Long term effects oophorectomy, at a young age, on bone health

Everolimus for postmenopausal women with advanced breast cancer

Randomized Phase II Study in Patients with HER2-Positive Breast Cancer

Influence of age and BRCA status on contralateral breast cancer risk

Novel agents and proteasome inhibitors in myeloma

Advances in peripheral T-cell lymphoma

Final results of the phase 3 VISTA trial: bortezomib-melphalan-prednisone (VMP) vs melphalan-prednisone (MP) for multiple myeloma

Translational research and proteasome inhibitors in multiple myeloma

CLEOPATRA trial to evaluate the efficacy and safety of pertuzumab + trastuzumab + docetaxel